Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

312
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
312
Tissue Transplantation01:24

Tissue Transplantation

875
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
875
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

290
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
290

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Safety and Immunogenicity of Live-Attenuated Measles-Mumps-Rubella Vaccination After Pediatric Heart Transplantation.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation·2026
Same author

Ionizing Radiation Exposure From Imaging in Pediatric Solid Organ Transplant Recipients.

Pediatric transplantation·2026
Same author

Poorly functioning right ventricle, pulmonary regurgitation, and atrial septal defect: an unfavorable combination for one-and-one-half ventricle circulation.

Pediatric radiology·2026
Same author

Safety and immunogenicity of varicella-zoster vaccination in pediatric heart transplant recipients.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation·2026
Same author

Early Experience with the First Canadian Paediatric Fontan Long-Term Follow-up Clinic.

Pediatric cardiology·2026
Same author

From sudden stroke to heart transplant: unmasking restrictive cardiomyopathy in an adolescent: a case report.

European heart journal. Case reports·2026

Related Experiment Video

Updated: Jan 10, 2026

A Simplified Model for Heterotopic Heart Valve Transplantation in Rodents
06:33

A Simplified Model for Heterotopic Heart Valve Transplantation in Rodents

Published on: September 21, 2021

2.7K

Unique Challenges in Paediatric Heart Transplantation.

Alyssa Power1, Anne I Dipchand1

  • 1Division of Cardiology, The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.

The Canadian Journal of Cardiology
|November 26, 2025
PubMed
Summary

Pediatric heart transplantation is crucial for end-stage heart disease but faces challenges. Addressing these issues is key to improving long-term outcomes for children receiving heart transplants.

Keywords:
adolescent heart transplantdonor selectionheart transplantationinfant heart transplantpsychosocial factorsvaccination

More Related Videos

A Porcine Heterotopic Heart Transplantation Protocol for Delivery of Therapeutics to a Cardiac Allograft
08:30

A Porcine Heterotopic Heart Transplantation Protocol for Delivery of Therapeutics to a Cardiac Allograft

Published on: February 14, 2022

3.1K
A Rodent Model of The Ross Operation: Syngeneic Pulmonary Artery Graft Implantation in A Systemic Position
11:20

A Rodent Model of The Ross Operation: Syngeneic Pulmonary Artery Graft Implantation in A Systemic Position

Published on: April 1, 2022

3.4K

Related Experiment Videos

Last Updated: Jan 10, 2026

A Simplified Model for Heterotopic Heart Valve Transplantation in Rodents
06:33

A Simplified Model for Heterotopic Heart Valve Transplantation in Rodents

Published on: September 21, 2021

2.7K
A Porcine Heterotopic Heart Transplantation Protocol for Delivery of Therapeutics to a Cardiac Allograft
08:30

A Porcine Heterotopic Heart Transplantation Protocol for Delivery of Therapeutics to a Cardiac Allograft

Published on: February 14, 2022

3.1K
A Rodent Model of The Ross Operation: Syngeneic Pulmonary Artery Graft Implantation in A Systemic Position
11:20

A Rodent Model of The Ross Operation: Syngeneic Pulmonary Artery Graft Implantation in A Systemic Position

Published on: April 1, 2022

3.4K

Area of Science:

  • Pediatric Cardiology
  • Cardiovascular Surgery
  • Transplantation Medicine

Background:

  • Heart transplantation is the standard treatment for pediatric end-stage heart disease unresponsive to other therapies.
  • Critically ill children awaiting transplant face high mortality, with increasing reliance on ventricular assist devices.
  • Despite survival improvements, challenges remain in optimizing graft function, patient longevity, and quality of life post-transplant.

Purpose of the Study:

  • To review key challenges in pediatric heart transplantation.
  • To discuss unique considerations across the pediatric age spectrum, from neonates to adolescents.
  • To highlight areas for future improvement in pediatric heart transplant care.

Main Methods:

  • This is a review article, synthesizing current knowledge and challenges in the field.
  • It discusses specific issues including age-related features, immunological barriers, and logistical considerations.
  • The review covers topics such as ABO-incompatible transplants, rejection surveillance, and psychosocial support.

Main Results:

  • Pediatric heart transplantation involves unique challenges related to age, physiology, and immunology.
  • Specific issues include infant and adolescent considerations, ABO-incompatibility, and donor selection criteria.
  • Limitations in rejection surveillance and the need for long-term psychosocial support are critical.

Conclusions:

  • Optimizing pediatric heart transplantation requires addressing age-specific needs and immunological challenges.
  • Improving graft survival and patient quality of life necessitates advancements in surveillance, support, and donor matching.
  • Further research and clinical strategies are needed to overcome existing barriers in pediatric heart transplantation.